Skip to main content
Clinical Trials/ACTRN12613000895785
ACTRN12613000895785Not yet recruiting未知

A pilot study to investigate the effects of one week of treatment with acetazolamide on the arterial levels of carbon dioxide in patients receiving non-invasive ventilation for the treatment of obesity hypoventilation syndrome

niversity of Otago, Wellington0 sites10 target enrollmentStarted: August 12, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomised trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 99 Years (—)
Sex
All

Inclusion Criteria

  • Diagnosis of obesity hypoventilation syndrome
  • Currently receiving non-invasive ventilation in s-mode
  • No hospitalisation with decompensation of respiratory failure for at least 3 months
  • Willing and able to give informed consent

Exclusion Criteria

  • Unable to provide informed consent
  • Poor renal function (eGFR <30ml/min)
  • Poor compliance with non-invasive ventilation (average usage less than 4 hours per night)
  • Allergy or previous adverse reaction to sulphur drugs
  • Use of supplemental oxygen
  • Any other safety concern at investigators discression

Investigators

Sponsor
niversity of Otago, Wellington

Similar Trials